HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Shen Selected Research

xiaoyu zhixue

6/2008Effect of Xiaoyu Zhixue Tablet on the expression of platelet membrane glycoprotein I b/IX/V complex in patients with chronic renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Shen Research Topics

Disease

249Neoplasms (Cancer)
05/2024 - 05/2003
139Stomach Neoplasms (Stomach Cancer)
05/2024 - 06/2006
64Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 05/2003
38Adenocarcinoma
05/2024 - 12/2011
29Neoplasm Metastasis (Metastasis)
04/2024 - 09/2008
29Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2023 - 11/2004
25Gastrointestinal Neoplasms (Gastrointestinal Cancer)
04/2024 - 05/2008
24Disease Progression
12/2023 - 12/2012
23Esophageal Squamous Cell Carcinoma
05/2024 - 06/2007
18Hypertension (High Blood Pressure)
02/2023 - 06/2008
16Microsatellite Instability
01/2024 - 01/2020
15Diarrhea
01/2023 - 12/2007
14Infections
03/2024 - 06/2006
14Breast Neoplasms (Breast Cancer)
12/2023 - 01/2011
14Spinal Cord Injuries (Spinal Cord Injury)
05/2022 - 04/2012
12Esophageal Neoplasms (Esophageal Cancer)
02/2024 - 03/2012
12Carcinoma (Carcinomatosis)
10/2023 - 08/2004
12Neutropenia
01/2023 - 05/2008
11Inflammation (Inflammations)
04/2023 - 08/2008
11Osteoporosis
01/2023 - 11/2007
9Hepatocellular Carcinoma (Hepatoma)
12/2022 - 11/2014
8Stroke (Strokes)
04/2024 - 01/2017
8Glioma (Gliomas)
03/2023 - 11/2015
8Postmenopausal Osteoporosis
01/2023 - 08/2007
8Nasopharyngeal Carcinoma
01/2022 - 04/2015
7Lung Neoplasms (Lung Cancer)
04/2024 - 09/2013
7Anemia
08/2023 - 01/2020
7Fibrosis (Cirrhosis)
01/2023 - 04/2009
7Carcinogenesis
12/2022 - 12/2015
7Disease Resistance
09/2021 - 02/2009
6Hypoxia (Hypoxemia)
04/2024 - 10/2014
6Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2023 - 01/2016
6Fatigue
10/2023 - 06/2007
6Body Weight (Weight, Body)
08/2023 - 04/2009
6Lymphoma (Lymphomas)
08/2023 - 08/2012
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2011
6Melanoma (Melanoma, Malignant)
01/2022 - 09/2013
5Pancreatic Neoplasms (Pancreatic Cancer)
11/2023 - 08/2007
5Colitis
08/2023 - 08/2008
5Exanthema (Rash)
10/2022 - 01/2014

Drug/Important Bio-Agent (IBA)

54Biomarkers (Surrogate Marker)IBA
05/2024 - 06/2008
46Immune Checkpoint InhibitorsIBA
02/2024 - 01/2019
33Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2010
29Cisplatin (Platino)FDA LinkGeneric
01/2023 - 05/2003
28Paclitaxel (Taxol)FDA LinkGeneric
04/2024 - 06/2007
26Fluorouracil (Carac)FDA LinkGeneric
10/2023 - 05/2003
24Trastuzumab (Herceptin)FDA Link
12/2023 - 08/2010
21Capecitabine (Xeloda)FDA Link
01/2023 - 12/2008
20Imatinib Mesylate (Gleevec)FDA Link
11/2023 - 11/2004
20Irinotecan (Camptosar)FDA LinkGeneric
04/2023 - 12/2007
18human ERBB2 proteinIBA
12/2023 - 08/2010
16RNA (Ribonucleic Acid)IBA
03/2024 - 06/2007
16Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2023 - 03/2008
15Tyrosine Kinase InhibitorsIBA
05/2024 - 12/2011
14Monoclonal AntibodiesIBA
11/2023 - 08/2010
13Cetuximab (Erbitux)FDA Link
05/2022 - 05/2008
12Phosphotransferases (Kinase)IBA
05/2024 - 06/2017
12Sunitinib (Sutent)FDA Link
11/2023 - 12/2011
11LigandsIBA
01/2024 - 08/2007
11PlatinumIBA
12/2023 - 11/2013
10HMPL-013IBA
04/2024 - 01/2017
10Leucovorin (Folinic Acid)FDA Link
01/2022 - 05/2003
10MicroRNAs (MicroRNA)IBA
01/2022 - 03/2012
9Messenger RNA (mRNA)IBA
04/2024 - 06/2016
9DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2004
9Indicators and Reagents (Reagents)IBA
01/2022 - 03/2008
8surufatinibIBA
05/2024 - 11/2020
8toripalimabIBA
05/2024 - 01/2020
7ErbB Receptors (EGF Receptor)IBA
12/2023 - 01/2011
7pembrolizumabIBA
12/2023 - 04/2019
7B7-H1 AntigenIBA
01/2023 - 01/2020
7Therapeutic UsesIBA
10/2022 - 05/2003
7regorafenibIBA
01/2022 - 01/2020
7CateninsIBA
01/2022 - 01/2013
6GemcitabineFDA Link
04/2024 - 08/2007
6ClaudinsIBA
03/2024 - 04/2020
6NivolumabIBA
02/2024 - 01/2021
6CytokinesIBA
01/2024 - 08/2008
6tislelizumabIBA
10/2023 - 01/2020
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2023 - 01/2020
6Bevacizumab (Avastin)FDA Link
03/2023 - 10/2011
6ParaffinIBA
11/2022 - 08/2004
5Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 10/2007
5Circulating Tumor DNAIBA
12/2023 - 09/2017
5Long Noncoding RNAIBA
11/2023 - 01/2020
5Alanine Transaminase (SGPT)IBA
08/2023 - 12/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2023 - 02/2012
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 11/2014
5GlucocorticoidsIBA
01/2023 - 06/2017
5Docetaxel (Taxotere)FDA Link
01/2023 - 01/2016
5Interleukin-6 (Interleukin 6)IBA
12/2022 - 10/2009

Therapy/Procedure

139Therapeutics
05/2024 - 05/2002
120Drug Therapy (Chemotherapy)
05/2024 - 06/2007
55Immunotherapy
05/2024 - 01/2016
14Radiotherapy
01/2023 - 06/2007
9Transplantation
03/2024 - 05/2002
8Neoadjuvant Therapy
12/2023 - 06/2012
8Aftercare (After-Treatment)
01/2020 - 06/2006
7Precision Medicine
12/2023 - 02/2012
5Chemoradiotherapy
08/2023 - 06/2015